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Abstract.  Previous studies have shown that temper- 
ature-sensitive, myo2-66 yeast arrest as large,  unbud- 
ded cells that accumulate vesicles within their 
cytoplasm (Johnston,  G. C., J.  A.  Prendergast,  and 
R. A.  Singer.  1991. J.  Cell Biol. 113:539-551).  In this 
study we show that myo2-66 is synthetically lethal in 
combination with a  subset of the late-acting sec muta- 
tions. Thin  section electron miscoscopy shows that the 
post-Golgi blocked secretory mutants,  secl-1 and sec6-4, 
rapidly accumulate vesicles in the bud, upon brief in- 
cubations at the restrictive temperature.  In contrast, 
myo2-66 cells accumulate vesicles predominantly in 
the mother cell.  Double mutant analysis also places 
Myo2 function in a post-Golgi stage of the secretory 
pathway.  Despite the accumulation of vesicles in myo2- 
66 cells, pulse-chase studies show that the transit 
times of several secreted proteins,  including  invertase 
and ot factor, as well as the vacuolar proteins,  carboxy- 
peptidase Y  and alkaline phosphatase,  are normal. 
Therefore the vesicles which accumulate in this mu- 
tant may function on an exocytic pathway that trans- 
ports a  set of cargo proteins that is distinct from those 
analyzed.  Our observations are consistent with a role 
for Myo2 in transporting  a class of secretory vesicles 
from the mother cell along actin cables into the bud. 
T 
HE yeast Saccharomyces cerevisiae exhibits a high de- 
gree of cell polarity.  The localized incorporation of 
cell surface constituents causes the daughter cell to ap- 
proach the size of the mother cell at which time cell division 
ensues.  Bud initiation as well as bud development rely on a 
wide array of gene products including ACT1, BUD1-5, BEM1, 
CDC24, CDC42, and CDC43 (for a recent review see Mad- 
den et al., 1992). Polarized growth occurs via the fusion of 
secretory vesicles with the plasma membrane of the bud. Re- 
cent work (Preuss et al., 1992) suggests that components of 
the secretory pathway, such as the ER and Golgi complex, 
may be transported into the bud to enable polarized growth. 
A polarized actin cytoskeleton is associated with the local- 
ized deposition of cell surface components (Adams and Prin- 
gle,  1984;  Kilmartin  and  Adams,  1984),  whereas  intact 
microtubules are not necessary for this process (Huffaker et 
al., 1988). Temperature-sensitive  mutations in the essential 
yeast gene encoding actin, AC'H, result in vesicle accumula- 
tion, the predominance of unbudded cells, and the accumula- 
tion of the secretory protein invertase within cells at the re- 
strictive  temperature (Novick and Botstein,  1985). 
A variety of proteins which interact  with actin have been 
identified in yeast (see references within Welch et al., 1994; 
Brown, 1993; Bretscher et al.,  1994). These include yeast 
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capping protein (Capl and Cap2) (Amatruda et al.,  1990), 
actin-binding protein (Abpl), fimbrin (Sac6), profilin (Pfyl), 
cofilin (Coil), and tropomyosin  (Tpml).  SLA/and SL42 en- 
code proteins required for the formation of the conical actin 
cytoskeleton (Holtzman et al., 1993). Recently, the require- 
ment for actin  and fimbrin  in yeast endocytosis has been 
demonstrated (Kubler and Riezman,  1993). The character- 
ization of the yeast actin cytoskeleton at the ultrastructural 
level has provided new insight into its possible functions in 
the cell. Cortical actin patches  were found associated with 
the cell surface via plasma membrane invaginations,  giving 
rise to speculations about the role of  this structure in cell wall 
growth (Mulholland  et al., 1994). Since polarized growth in 
yeast is associated with a polarized actin cytoskeleton, it has 
been suggested that an actin-based  motor fulfills the role of 
transporting  vesicles  into the bud. 
To date, four myosins have been identified in yeast. First, 
the MY01 gene product was identified as the conventional (or 
class 1I) myosin in yeast and shown to be required for cytoki- 
nesis (Watts et al., 1987). A class I myosin, Myo3, has been 
identified,  but its  function  is  as yet unknown  (Goodson, 
H. V., and J. A. Spudich.  1993. Mol. Biol. Cell. 4:156a). 
In the past few years, a rapidly growing number of unconven- 
tional myosins have been identified from a variety of organ- 
isms (Cheney and Mooseker,  1992). The yeast MY02 and 
MY04 gene products are class V myosins (Johnston  et al., 
1991; Haarer et al., 1994). They contain a myosin-like head 
domain which is conserved among the members of this class, 
a series of IQ motifs involved in calrnodulin binding,  and a 
relatively short coiled-coil region followed by a globular dis- 
tal tail domain.  The COOH-terminal portion of these myo- 
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osins.  Strain 
Class V myosins have been implicated in the transport of 
membrane-bounded organdies in a variety of organisms (Ti-  NY 3 
ms, 1993). Mutations in the murine Dilute locus, which en-  NY 13 
codes an essential class V myosin, leads to the loss of coat  NY 17 
color in dilute mice (Mercer et al.,  1991). This phenotype  NY 57 
arises  from a  defect in the transfer of pigment-containing  NY 61 
NY 64 
melanosomes into the keratinocytes of the developing hair  NY 130 
shaft. Melanosomes in dilute mice exhibit mostly a perinu-  NY 180 
clear distribution, whereas in wild-type mice the melano-  NY 402 
somes are evenly distributed between the cell body and den-  NY 405 
drites (Wei, M. C., V. Ipe, and J. Mercer. 1994. Mol. Biol.  NY 410 
Cell. 5:381a). More severe alleles of dilute result in death  NY 412 
from neurological seizures.  An additional member of the  NY 414 
class V myosin family is the chick brain myosin V protein  NY 415 
(Espindola et ai.,  1992).  Chick brain myosin V  has been  NY 418 
well-characterized biochemicaily as an actin-activated ATP-  NY 420 
NY 422 
ase,  and  it has  been  localized to  the  perinuclear region  NY 426 
and the tips of cellular processes in neurons (Espreafico et  NY 430 
ai., 1992; Cheney et al., 1993). This localization suggests an  NY 431 
association of chick myosin V with vesicles. Temperature-  NY 579 
sensitive myo2-66 mutants, defective in a yeast class V myo-  NY 738 
sin, arrest as large, unbudded cells with mislocaiized actin  NY 756 
and chitin (Johnston et al.,  1991).  Furthermore, myo2-66  NY 829* 
ceils accumulate vesicles throughout their cytoplasm upon  NY 830* 
shifts to the restrictive temperature. Nonetheless, the peri-  NY 895* 
NY 896*  plasmic enzyme invertase is still secreted in myo2-66 mu- 
NY 919, 
tants.  Based on these findings Johnston et ai.  (1991) pro-  NY 922* 
posed that Myo2 functions as a motor to transport post-Golgi  NY 1005, 
secretory vesicles into the growing bud. It was hypothesized  NY 1006, 
that the vesicle accumulation in this mutant is due to a kinetic  NY 1031, 
lag in their transport, since the vesicle motor is defective. 
To investigate the possible role of Myo2 in various vesicu-  NY 1032, 
lar transport pathways,  we have further characterized the  NY 1033, 
myo2-66 mutant  through  analysis  of genetic interactions,  NY 1125, 
epistasis  tests  and  through pulse-chase studies  of protein  NY 1180§ 
transport. Using electron microscopy, we have also exam-  NY  1235, 
ined the phenotype of  myo2-66cells shifted to 37°C for short 
time periods to determine the primary site of vesicle ac- 
cumulation. These studies indicate that Myo2 is involved in 
a  post-Golgi stage of the secretory pathway.  Our observa- 
tions are consistent with the model that Myo2 functions to 
transport vesicles from the mother cell into the bud. 
Materials and Methods 
Yeast Strains,  Media, and Reagents 
The Saccharomyces cerevisiae strains used in this study are described in Ta- 
ble I. Cells were grown in YP medium containing 1% Bacto-yeast extract 
and 2% Baeto-peptone (Difco Laboratories Inc., Detroit, MI), with either 
2% glucose (rich medium, YPD) or 0.1% glucose (low glucose media). To 
change  the  growth  medium,  cells  were  pelleted  and  resuspended  in 
prewarmed, fresh medium. For the pulse-chase studies, cells were grown 
in minimal media containing 0.7% yeast nitrogen base without amino acids 
(Difco), 2 % glucose, and supplemented for auxotrophic requirements as de- 
scribed by Sherman et al. (1974)  when necessary. The absorbance of cell 
suspensions was measured at 599 nm in a model No. 4054 spectrophotome- 
ter (Pharmacia LKB Biotechnology, Piscataway,  NJ). 
Sorbitol, ~x factor, PMSE Protease Inhibitor Cocktail-PIC (1 mg/mi each 
of leupeptin, chymostatin, pepstatin, aprotinin, and antiparin), Pronase E, 
nocodazole, and Triton X-100 were obtained from Sigma Chem. Co. (St. 
Louis,  MO).  Chemicals  for  SDS-PAGE  were  obtained ,from  BioRad 
Laboratories (Richmond, CA). SPURR embedding medium for electron 
Table L  Yeast Strains 
MATa ura3-52  sec 1-1 
MATa ura3-52 
MATa ura3-52  sec 6-4 
MATa ura3-52  sec 9-4 
MATa ura3-52  sec 10-2 
MATa ura3-52  sec 13-1 
MATa ura3-52  sec 2-41 
MATer ura3-52  Ieu2-3,112 
MATa ura3-52  sec 5-24 
MATa ura3-52  sec 4-8 
MATa ura3-52  sec 8-9 
MATa ura3-52  sec 3-2 
MATa ura3-52  sec 13-1 
MATa ura3-52  sec 16-2 
MATa ura3-52  sec 17-1 
MATa ura3-52  sec 19-1 
MATa ura3-52  sec 20-1 
MATa ura3-52  sec 22-3 
MATa ura3-52  sec 14-3 
MATa ura3-52  sec 18-1 
MATtx pep4: : URA3  leu2-3,1t2 
MATa ura3-52  sec 12-4 
MATa ura3-52  sec  7-1 
MATa his6 ural  myo2-66 
MATtx  his6 ural  myo2-66 
NY830  x  NY  17 
NY830  x  NY431 
NY  830  x  NY 756 
NY  830  x  NY 414 
MATc~ ura3-52  1eu2-3,112  myo2-66 
MATa ura3-52  leu2-3,112 myo2-66 
NY  1006 transformed to Ura+  with pRB58 
(SUC2 on 2  #m plasmid) 
NY  1033 transformed to Ura+  with pRB58 
MATa ura3-52  1eu2-3,112 
MATtx  myo2-66 his4-619 pep4: :URA3 
MAT a  end4::LEU2  barl-I  lys2 ura3-52  his4-619 
1eu2-3,112 
MAT el myo2-66 end4::LEU2  ura3-52 
* from G. Johnston. 
* This study. 
§ from H. Riezman. 
microscopy was obtained from Polysciences, Inc. (Worthington, PA). 35S- 
trans label and Zymolyase 100-T were purchased from ICN ImmunoBiolog- 
icals (Costa Mesa,  CA).  [35S] In vitro cell-labeling mix was purchased 
from Amersham Corp. (Arlington Heights, ILL 
Yeast Genetic Techniques 
Yeast transformation was performed by the alkali  cation treatment method 
(Ito et al., 1983) and transformants were selected on minimal medium sup- 
plemented by the appropriate amino acids at 25°C.  Crosses of strains, 
sporulation of diploids, tetrad dissections, complementation, and mating 
type determination were performed as described by Sherman et al. (1974). 
Double mutants were constructed between myo2-66 and various sec or end 
genes by crossing the appropriate strains, sporulating the diploids at 25°C, 
and dissecting the resulting tetrads. In cases where 2:2 segregation of tem- 
perature sensitive: temperature-resistant spores was observed, the tempera- 
ture-sensitive spores were picked and tested for mating type and auxotrophy. 
MATa spores were selected and complementation analysis confirmed that 
the strains were defective in both MY02 and SEC or END genes. 
Thin Section Electron Microscopy 
Cells were grown overnight in YPD medium to an As~ of 1.0. For syn- 
chronization experiments, 13.20D units were harvested and incubated in 
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were then washed in YP, resuspended in 60 ml fresh YPD, and incubated 
at 25°C for I h to induce small bud formation. Temperature shifts were then 
performed by incubating the cells at 37"C for short periods. At time points, 
cells were harvested by filtration and washed with 10 ml 0.1 M cacodylate, 
pH 6.8, reharvested and resuspended in 10 ml cacodylate, pH 6.8, containing 
3 % glutaraldehyde. After 1 h at room temperature, the cells were incubated 
on ice overnight at 4°C. Fixed ceils were then washed twice in 50 mM phos- 
phate buffer, pH 7.0, and incubated in 2 ml 50 mM phosphate buffer, pH 
7.0, containing 0.125 mg/ml Zymolyase 100-T for 40 min at 37°C. After be- 
ing  washed twice in  ice  cold 0.1  M  cacodylate buffer,  the  cells were 
resuspended in 2 ml 0.1 M cacodylate with 2% OsO4 and incubated for 1 h 
at 4"C. The cells were washed in sterile H20 three times, resuspended in 
2 ml of 2 % aqueous uranyl acetate, and incubated at room temperature for 
1 h. This was followed by two washes in sterile H20, formation into 2 % 
agar blocks, and finally dehydration by a series of graded ethanol washes 
(1 wash each of 50, 70, 90, and 100% EtOH, and then four washes of fresh 
100%  EtOH). The dehydrated blocks were washed in 100%  acetone and 
embedded in SPURR epoxy medium. Thin sections were cut, stained with 
lead citrate, and poststained with uranyl acetate. Sections were analyzed on 
a Philips 301  electron microscope at 80 kV. 
To count vesicles, budded cells containing a nucleus and/or vacuole and 
a well-defined neck region were selected at random at low magnification. 
The neck region was considered as part of the mother cell in determining 
vesicle density in the mother vs the bud. Only vesicles whose membranes 
could be clearly distinguished were counted. The cytoplasmic area of each 
cell was determined on a Zeiss MOP-3 magnetized tablet (Carl Zeiss, Inc.) 
by outlining the surface of each mother cell and bud, and subtracting all 
internal surfaces including the nucleus, mitochondria, lipid droplets, and 
vacuoles. The number of vesicles per ~m  2 was determined for both the 
mother and bud of each cell. At least 25-30 samples from 1-3 independent 
experiments were analyzed per time point. 
Pulse Chase Experiments 
m~2-66 and wild-type (NY 1006 and NY 1033) strains were transformed 
to Ura+ with pRB58, a high copy number (2 t~m) plasmid containing the 
SUC2 gene which encodes invertase (Carlson and Botstein, 1982).  The 
resulting invertase-overproducing strains were grown overnight in  sup- 
plemanted minimal media with 2% glucose at 25*C to an OD~99 of 0.5. 25 
OD  units of cells were harvested by centrifugation and resuspended in 
medium containing 0.1% glucose to derepress invertase synthesis. After in- 
cubation  in this  medium for  30  min  at  25°C,  cells were pelleted and 
resuspended in 25 ml of spheroplast buffer containing 0.1% glucose, 1 M 
sorbitoi, 50 mM KPi (pH 7.5),  50 mM ~-mercaptoethanol, and 1 mg of 
Zymolyase-100 T. Spheroplasts were formed by incubation at 25°C for 90 
min with gentle agitation, and then pelleted gently and resuspended in 50 
ml recovery buffer containing supplemented minimal media, 0.1% glucose, 
1 M sorbitol, and 20 mM Pipes (pH 6.6). The spheroplasts were incubated 
at 25°C for 60 rain to allow cell metabolism to return to normal levels. The 
recovered spheroplasts were then shifted to 37"C for 30 rain, pelleted gently 
and resuspended in 1 ml of recovery buffer. After incubating the recovered 
spberoplasts for 10 min at 37"C, 355-tran$ label was added to 0.3 mCi/ml 
and the spheroplasts were labeled for 4 min at 37°C. The chase was initiated 
by the addition of  cysteine and methionine (in recovery buffer) to a final con- 
centration of 5 mM. At various time points of chase (at 370C),  cell aliquots 
were removed to tubes on ice and pelleted in a microfuge to separate cells 
from supernatants (containing the periplasm). The cell pellets were resus- 
pended in 100/~1 of 1% SDS and the supernatants were made 1% in SDS 
and both samples were boiled for 3 min. Both samples were diluted with 
900/~1 of IP buffer (2 % Triton X-100 in PBS) and microcentrifuged for 10 
min at 40C to remove insoluble material. The supernatants were added to 
tubes containing 2/~1 anti-invertase antibody (generous gift of Dr. Susan 
Ferro-Novick) and incubated overnight at 40C.  The immunoprecipitates 
were collected on protein A-Sepharose beads (60 ~1 of a 3 % suspension 
per sample), washed twice with urea wash buffer containing 2 M urea-200 
mM NaCI- 100 mM Tris (pH 7.2)- 1% Triton X-100, washed twice with 
0.5%/3-mercaptoethanol and solubilized by boiling in 50 t~l 1× SDS sample 
buffer for 5 rain. Aliquots were counted by liquid scintillation, and 30-~tl 
samples were loaded onto 10%  SDS polyecrylamide gels with prestained 
high molecular weight markers (BRL). The gels were fixed in 0.5 M sodium 
salicylate-20% MeOH-1% glycerol, dried, and exposed to Kodak X-OMAT 
film overnight at  -70°C. 
The secretion of glycoproteins was also examined by a similar method. 
Cells were spheroplasted as above, and then regenerated in recovery buffer 
containing 2%  glucose for 1 h at 250C.  Nocodazole (15 /~g/ml plus  1% 
DMSO) or just DMSO alone was added to the recovering spheroplasts for 
30 min at 37"C. After centrifuging at 2,000 rpm for 5 min, the regenerated 
spheroplasts were resuspended in 1 ml of recovery buffer. At this point, ali- 
quots were removed, fixed, and processed for immunofluorescence micros- 
copy with anti-tubulin antibody to determine the effectiveness  of nocodazole 
treatment. The regenerated spberoplasts were incubated at 37"C for 10 min, 
35S-trans label was added to 0.3 mCi/ml for 5 min at 37°C, chase buffer 
was added (50 mM cysteinedmethionine), and at time points aliquots were 
removed and microcentrifuged to separate the cellular and external (se- 
creted) fraction. In these experiments, the cellular fraction was discarded, 
while the supernatant (containing secreted proteins) was boiled in 1% SDS. 
Samples were diluted by the addition of 1 ml of HSW containing 1% TX- 
100, 0.5 M NaCi, 20 mM Tris-Cl, pH 7.5, and clarified in a microfuge for 
15 re.in. The samples were precipitated with 100 t~l of a 20% slurry of Con 
A Sepharose for 2 h at 4"C. The Con A precipitates were washed with the 
following: (1% TX-100,  0.1%  SDS, 0.15 M  NaCI,  15 mM Tris, pH 7.5), 
(2 M urea, 1% TX-100, 0.2 M NaCI, 0.1 M Tris, pH 7.5),  HSW, and LSW 
(10 mM Tris, pH 7.5, 50 mM NaCI). The samples were then boiled in SDS 
sample buffer and 30/d loaded onto 10%  SDS polyacrylamide gels and 
processed for autoradiography as described. 
To examine the transit times of carboxypeptidase Y (CPY) t and alkaline 
phosphatase (ALP), a modification of the above protocol was used. 10D 
unit per sample per time point was incubated at 37°C for 30 rain. The cells 
were pelleted and resuspended in 0.5 ml of prewarmed media, and then 100 
#Ci of 355-trans label was added for 2 min (for CPY) or 5 rain (for ALP) 
at 37°C. Cells were chased with medium containing 10 mM cysteine and 
methionine, and at time points cell aliquots were removed and washed twice 
in 1 mi of 10 mM NAN3. The cell pellets were frozen in liquid nitrogen and 
thawed on ice to aid lysis. Cells were lysed by vortexing for 3 min at 4°C 
in the presence of 100 t~l 1% SDS and glass beads. The lysates were boiled 
immediately for 3 min, diluted with 0.9 ml of IP buffer and clarified by 
pelleting in a microfuge for 15 min at 4°C. The supernatants were added 
to tubes containing either anti-CPY antibody or anti-alkaline phosphatase 
antibody (generous gift of Dr. Tom Stevens) and incubated overnight at 4°C. 
Immunoprecipitates were collected as described above and washed three 
times in urea wash buffer, and then twice in 1% B-mercaptoethanol. Sam- 
ples were boiled in SDS sample buffer containing Bme for 5 min, and then 
loaded onto either 8 or 10%  SDS gels and treated as described above. 
Pulse chase experiments to study the life cycle of the a-factor receptor 
were also done by labeling intact cells as described in Davis et al. (1993). 
For protease susceptibility experiments, PEP4 deficient cells were used. 
0.15 OD units of cells per sample per time point were shifted to 300C  for 
30 rain and labeled with 0.15 mCi 35S in vitro labeling mix for 10 rain. 
Cells were chased with 10 mM cysteine and methionine in media at 30°C. 
At time points, cell aliquots were removed, made 10 mM in both Nalq3 and 
KF and kept on ice. All samples were washed once in  10 mM KF and 
NAN3, and then resuspended in  100 #1 digestion buffer (DB) containing 
1.4 M  sorbitoi,  10 mM KF, 10 mM NAN3, and 25 mM Tris-Cl, pH 7.5, 
plus 0.5 % ~-mercaptoethanol for 30 rain at 37°C before being digested with 
1 mg/ml Pronase E  at 37"C  for 1 h.  Protease was washed away by two 
washes in DB containing 1 mM PMSF, and then the samples were treated 
with DB plus 0.05 mg/ml Zymolyase 100-T and 0.3% /~-mercaptcethanol 
for 30 min at 30°C. The spheroplasts were gently pelleted then resuspended 
in 50 t~l of lysis buffer containing 8 M urea, 2.5% SDS, 40 mM Tris, pH 
6,8, 0.1 mM EDTA and 1% B-mercaptoethanol. These samples were boiled 
for 5 min, diluted with 0.9 ml of IP buffer containing 10 mM Tris-Cl, pH 
8.0, 0.1% Triton-X-100,  2 mM EDTA, 1 mM PMSF, and 1:1,000 vol of PIC 
and clarified as described above. The supernatant was removed to a tube 
containing  3  /~1  of anti-STE3  antibody  (generous  gift  of Dr.  George 
Sprague) plus 70/~1 of a 3 % suspension of protein A-Sepharose CLAB and 
incubated for 90 min at 40C. (The antibody was first preadsorbed to the pro- 
tein A-Sepharose beads for 4 h at 4"C). An aliquot of the supernatant was 
also counted by liquid scintillation. Immunoprecipitates were collected as 
described above and washed four times with IP buffer plus 0.1% SDS. The 
samples were then boiled for 5 min in SDS sample buffer with/~-mereapto- 
ethanol, counted by liquid scintillation and loaded on 10% SDS gels with 
prestained high molecular weight standards. After electrophoresis, the gels 
were treated as described above. 
Secretion of c~ factor was examined by the method described in Graham 
and Emr (1991). MATot ceils were grown to mid-log phase in supplemented 
minimal media with 2% glucose overnight at 25°C, and then 10 0DU/ml 
cells in media containing 1 mg/ml BSA were shifted to 37"C for 30 min. 
1. Abbreviations used in this paper: ALP, alkaline phosphatase; CPY, car- 
boxypeptidase Y; DB, digestion buffer; wt, wild type. 
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trans label (or in vitro labeling mix), and then chased with 10 mM cysteine 
and methionine in media. At time points, cell aliquots were removed and 
pelleted in a microfuge to separate cells from media. Both samples were 
precipitated with 5 % "ICA to terminate the chase, washed twice in cold ace- 
tone, dried, resuspended in 100/zl buffer containing 50 mM Tris, pH 7.5, 
6 M urea, 1 mM EDTA, 1% SDS, and lysed by vortexing with glass beads. 
After boiling the samples, a  MATa lysete of equivalent cell density was 
added to reduce background in the immunoprecipitation. 900 t~l of  dilution 
buffer containing 1.25% TX-100,  190 mM NaCI, 6 mM EDTA, and 50 mM 
Tris, pH 7.5, was added to each sample. Samples were clarified as described 
above, and then anti-c~ factor antibody was added to the supernatant and 
incubated overnight at 4"C. The immune complexes were collected as de- 
scribed and washed twice in dilution buffer and once in 1% B-mercapto- 
ethanol. The washed immunoprecipitates were boiled for 5 rain in 20 #1 
SDS  sample buffer containing /~-mercaptoethanol. These samples were 
counted by liquid scintillation and loaded onto a 17 % SDS-polyacrylamide 
gel with prestained low molecular weight standards. After electrophoresis, 
the gels were fixed and treated as described elsewhere (Julius et al., 1984a). 
Results 
Double Mutants of myo2-66 and a Subset of 
Late-acting sec Genes Are Inviable at 25°C 
Mutant alleles of genes which function on the same pathway 
or on parallel pathways often display synthetic effects in com- 
bination with each other. Many of the temperature-sensitive 
sec mutants blocked at the post-Golgi stage of the secretory 
pathway are inviable even at the permissive temperature when 
combined to generate haploid double sec mutants (Salminen 
and Novick, 1987). If the MY02 gene product is directly or 
indirectly involved in facilitating the transport of post-Golgi 
vesicles, one might predict that MY02 would exhibit interac- 
tions with genes required for secretion. Thus we initially ex- 
amined double mutants between myo2-66 and alleles of the 
early- and late-acting sec genes (Novick et al.,  1980,  1981). 
Crosses were made between myo2-66 and representative 
alleles of ER-Golgi (early) sec genes and post-Golgi (late) 
sec  genes.  Diploids  were  sporulated  at  25°C  and  12-24 
tetrads per cross were dissected and analyzed.  In crosses 
with  seven of the  late-acting sec genes  (sec2-41,  see4-8, 
sec5-24,  see8-9,  see9-4,  seclO-2,  and  see15-1),  approxi- 
mately one-fourth of the meiotic products were inviable at 
the permissive temperature. The pattern of temperature sen- 
sitivity among the viable progeny indicated that these myo2- 
66, sec double mutant combinations were lethal at 25°C (Ta- 
ble II). In tetrads with four viable spores (parental ditype) 
at 25°C, all were temperature sensitive. Tetrads containing 
three viable spores (tetratype) contained two which were 
temperature sensitive. In cases where only two spores were 
viable at 25°C (nonparental ditype), both were temperature 
resistant. In contrast, the combinations of myo2-66 and the 
early-acting sec genes were clearly not synthetically lethal as 
seen by the pattern of spore viability. In all  tetrads,  four 
spores were viable at 25°C and the pattern of temperature 
sensitivity  among  these  progeny  indicated  independent 
segregation of the myo2-66 and sec mutations. Thus, myo2- 
66 is  synthetically lethal  with  see2-41,  see4-8,  sec5-24, 
see8-9, see9-4, seclO-2, and sealS-1.  As shown in Table II, 
this subset of late-acting sec genes also genetically interacts 
with see4-8 (Salminen and Novick,  1987). 
Previous work has shown that duplication of SEC4 par- 
tially suppresses the temperature sensitivity of most of the 
sec mutants with which see4-8 is synthetically lethal (Salmi- 
Table II. * Summary of Viability of myo2-66,  sec Double 
Mutants at 25°C 
ER-Golgi  myo 2-66 x  sec 4-8 x 
sec  7-1  +  + 
sec  12-4  +  + 
sec  13-1  +  + 
sec  14-3  +  + 
sec  16-2  +  + 
sec  17-1  +  + 
sec  18-1  +  + 
sec  19-1  +  + 
sec 20-1  +  + 
sec 22-3  +  + 
Golgi-PM 
sec  1-1  +  + 
sec  2-41  -  - 
sec 3-2  +  + 
sec 4-8  -  NA 
sec 5-24  -  - 
sec 6-4  +  + 
sec 8-9  -  - 
sec 9-4  -  + 
sec 10-2  -  - 
sec 15-2  -  - 
* Strains were crossed at 25°C, diploids sporulated,  and tetrads dissected and 
analyzed on YPD plates at 25°C. 
nen and Novick, 1987). Duplication of SEC4 efficiently sup- 
presses the myo2-66  growth defect at 30°C and partially sup- 
presses  at  34°C  (data  not  shown).  Together,  these  data 
demonstrate that myo2-66 genetically interacts with a subset 
of late-acting SEC genes, and suggests that the Myo2 protein 
may function at the post-Golgi stage of  the secretory pathway 
or on a parallel pathway that shares many of  the same compo- 
nents. 
myo2-66 Mutants Are Not Defective in the Processing 
or Transport of lnvertase or ~  Factor 
Previous studies have shown that the myo2-66 mutation does 
not block the secretion of invertase at the restrictive tempera- 
ture (Johnston et al.,  1991). However, these studies did not 
test for the accumulation of an intracellular pool of invertase 
or for a ldnetic lag in export. We examined the transit time 
of invertase secretion by pulse-chase analysis. In yeast, in- 
vertase is found as a  constitutively expressed cytoplasmic 
protein and as a secreted glycoprotein regulated by hexose 
repression (Carlson and Botstein, 1982). The secreted pro- 
tein undergoes core glycosylation in the ER followed by man- 
nose extension in the Golgi to yield a mature high molecular 
weight species (Esmon et al.,  1981) that is released into the 
periplasm  of yeast cells.  To detect invertase in  immuno- 
precipitates, a high copy number plasmid bearing the SUC2 
gene which encodes invertase was introduced into myo2-66 
and wild-type strains. Pulse chase experiments on regener- 
ated myo2-66 spheroplasts revealed that the transit time for 
invertase is ,,05 min, similar to that of wild-type spheroplasts 
(Fig.  1). At the 0-min time point after a 4-min pulse, all of 
the immunoprecipitated invertase was  in its core glycosy- 
lated form and still within the cells for both mutant and wild- 
type samples. By two min of chase, some fully glycosylated 
invertase was found in the internal and external fraction of 
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secretion  are  equivalent  in 
myo2-66 and wild-type cells. 
Cells  containing  the  SUC2 
gene on a high copy plasmid 
(NY 1031, myo2-66, and NY 
1032,  wild  type)  were  first 
derepressed for invertase syn- 
thesis  at 25°C,  converted  to 
spheroplasts,  and then regen- 
erated. The recovered sphero- 
plasts were shifted to 37°C for 
30 min, and then labeled with 
35S-trans label for 4 min at 37°C, and chased with 5 mM cysteine and methionine for 0, 2, 5, 10, and 30 min at 37°C. Cell aliquots were 
microcentrifuged at time points to separate the cells from the media, and both internal and external fractions were boiled in 1% SDS and 
immunoprecipitated  with anti-invertase antibody as described  in Materials  and Methods.  The washed immunoprecipitates  were resus- 
pended in SDS sample buffer, loaded on 10% SDS gels, and processed for autoradiography. Both strains (m, myo2-66, w, wild type) secrete 
fully processed  invertase within 5 min of chase. 
both mutant and  wild-type strains.  After 5  rain  of chase, 
most of the glycosylated invertase was found secreted into 
the external fraction in both myo2-66and wild-type samples. 
By  10 min of chase,  all of the glycosylated invertase was 
found externally in both strains.  As a control for cell lysis 
we have quantitated the cytoplasmic, unglycosylated form of 
invertase by scanning densitometry and found that less than 
15 % of it is found in the secreted fraction (data not shown). 
Furthermore,  no other form of invertase was found within 
the cells, indicating that there was no internal accumulation 
of the secretory form of the protein or of any degradation 
products. This experiment clearly shows that newly synthe- 
sized invertase in myo2-66  cells is efficiently transported into 
the periplasm with wild-type kinetics. 
To address whether myo2-66 cells are defective in the pro- 
cessing or export of a protein which is normally secreted into 
the  media,  we next examined the transport of the peptide 
pheromone  ot  factor.  The  a  factor mating  pheromone  is 
processed  through  the  secretory  pathway  (Julius  et  al., 
1984a), and its final modification occurs via the conversion 
of  pro-or factor to mature o~ factor (a tridecapeptide) by pepti- 
dases in a late Golgi compartment (Julius et al.,  1984b; Wil- 
cox and Fuller,  1991).  The pulse chase experiment in Fig. 
2 shows that mature ot factor is secreted from both wild-type 
and mutant cells within 5 min of chase after labeling for 8 
min.  Furthermore,  although  o~  factor is  found  associated 
with  the  cells  at  the  initial  zero  time point,  a  significant 
amount is rapidly chased into the medium by 2 min. In addi- 
tion, no other form of a  factor is found accumulated within 
the cells (not shown). Thus, the ot factor processing compart- 
ment is functional in myo2-66 ceils, and the secretion of ot 
factor and invertase is unimpaired. 
Transport of  Major Glycoproteins Is Normal in 
myo2-66 Cells 
To examine the fates of additional exported proteins in myo2- 
66 cells, we studied the transport of several major secreted 
glycoproteins which bind to Con A. A pulse chase protocol 
was  performed  on  regenerated  wild-type  and  myo2-66 
spheroplasts, followed by Con A  precipitation.  Five major 
secreted glycoproteins (30,  35, 45,  116, and 200+ kD) were 
observed in both strains (Fig. 3). As Fig. 3 illustrates, wild- 
type (B) or myo2-66 (A) cells show similar kinetics of glyco- 
protein transport out of the cell. While the ll6-kD glycopro- 
tein is secreted even at the 0-min chase time point (after a 
5-min pulse), the 200+, 45, and 35 kD glycoproteins appear 
by 15 rain of chase. Finally, the 30-kD glycoprotein is chased 
into the secreted fraction by 30 min. Recently a gene encod- 
ing  a  high  copy suppressor  of myo2-66, SMY1, has  been 
identified and shown to have homology to kinesin (Lillie and 
Brown,  1992).  We  reasoned  that  if Smyl  functions  as  a 
microtubule-based motor to bypass a myo2-66 defect, dis- 
rupting microtubules in a myo2-66 mutant may cause an ob- 
servable block in secretion.  To address this possibility, we 
treated myo2-66 ceils  with  nocodazole during  the  Con A 
precipitation experiment. Samples processed in parallel for 
immunofluorescence showed that essentially all of the tubu- 
lin staining had disappeared in the nocodazole-treated cells 
(data not shown). Fig. 3 shows that myo2-66 and wild-type 
strains  exhibit  similar  kinetics  of  glycoprotein  secretion 
whether  treated  with  (+)  or  without  (-)  nocodazole.  It 
Figure 2. The secretion of mature ~ factor occurs with similar ki- 
netics in wild-type and myo2-66 cells. Cells (NY 1005, myo2-66, 
and NY 180, wt) were preshifted to 37°C for 30 min, and then la- 
beled with 35S-trans label for 8 min and chased with 10 mM cys- 
teine and methionine for 0, 2, 5, and 10 min. At each time point, 
cells were separated from the media by brief centrifugation,  sam- 
ples were TCA precipitated,  washed in acetone,  lysed with glass 
beads, and immunoprecipitated with anti-t~ factor antibody as de- 
scribed in Materials and Methods. The washed immunoprecipitates 
were resuspended  in SDS sample buffer and loaded onto a  17% 
SDS polyacrylamide gel and processed for autoradiography as de- 
scfibed in Materials and Methods. Mature t~ factor is completely 
secreted from the cells (c) into the medium (m) by 5 rain of chase 
in both myo2-66 and wild-type cells shifted to 37°C. 
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even after nocodazole treatment.  Regenerated spheroplasts treated 
(+) with  15/~g nocodazole and  1% DMSO or mock-treated  (-) 
with 1% DMSO were pulse labeled with 35S-trans label for 5 min, 
and then chased for the times indicated.  The cellular  and media 
fractions  were  separated  by microcentrifugation,  and the  media 
fraction was denatured by boiling in 1% SDS, and then precipitated 
with Con A Sepharose beads. The precipitates were washed, boiled 
in sample buffer, and loaded onto a 10% SDS polyacrylamide gel. 
The arrows indicate the appearance of the major secreted glycopro- 
teins. All of these glycoproteins are transported  out of the cell in 
both myo2-66  (.4) and wild-type (B) cells shifted to 37°C. Their ap- 
proximate molecular masses are (from top to bottom): 200+,  116, 
45,  35, and 30 kD. 
seems that the  35-kD  glycoprotein is more evident in the 
nocodazole-treated cells at the  15-min chase time point in 
both mutant and wild-type samples.  A  similar nocodazole 
treatment  was  applied  to  samples  in  the  invertase pulse- 
chase  experiment  described  in  Fig.  1.  In  this  case  also, 
nocodazole did not affect the kinetics of invertase secretion 
in myo2-66 cells (not shown). 
Eleven major proteins are found on the yeast cell surface, 
and most of these bind to Con A  (Novick and Schekman, 
1983). It has previously been shown that secretory mutants 
are defective in the transport of all of these major cell surface 
glycoproteins (Novick and Schekman, 1983). We conducted 
pulse  chase  experiments on  regenerated  spheroplasts  fol- 
lowed by protease protection and Con A  precipitations to 
examine the pathway of glycoprotein transport to the cell sur- 
face  in  myo2-66  and  wild-type  cells.  From  these  pulse- 
chase/protease protection  studies,  we  determined  that the 
same set of four glycoproteins (roughly 30, 50, 80, and 200+ 
kD in size) reached the cell surface and became protease- 
sensitive with the same kinetics in both myo2-66 and wild- 
type ceils (data not shown). The pattern of protease-resistant 
bands  was also  found to be identical  in  both  strains  (not 
shown).  Thus, a number of different membrane-bound and 
secreted proteins are correctly processed and delivered nor- 
mally in myo2-66 mutants, even under conditions of micro- 
tubule disruption. 
Since the plasma membrane ATPase accumulates in secre- 
tory vesicles found in late-acting sec mutants (Walworth and 
Novick,  1987),  we sought to determine if this protein was 
associated with vesicles in myo2-66 cells. Through immuno- 
fluorescence staining, pulse chase experiments, and column 
fractionation, we found that the plasma membrane ATPase 
of myo2-66 cells is correctly distributed on the yeast cell sur- 
face, is stable, and is not found on vesicles (data not shown). 
Vacuolar Transport Is Not Defective in 
myo2-66 Mutants 
Since transport to the cell surface and out of the cell seemed 
to  occur  normally  in  myo2-66  cells,  we  next  examined 
whether transport from the Golgi to the vacuole is impaired 
in  the myo2-66  mutant.  It has recently been shown  (Ray- 
mond et al.,  1992;  Vida et al.,  1993) that the transport of 
vacuolar proteins is directed from the Golgi complex via a 
prevacuolar  compartment  (or  endosome)  to  the  vacuole. 
Since the delivery of soluble and membrane-bound vacuolar 
proteins is thought to occur by somewhat different mecha- 
nisms  (Klionsky and  Emr,  1989),  we  chose to  study the 
transport of a  representative protein from each class. 
The soluble vacuolar protease carboxypeptidase Y (CPY) 
undergoes modifications in the ER and Golgi before arriving 
in the vacuole where it is cleaved by the PEP4 gene product 
to its mature 61-kD active form. The ER (67 kD) form or 
Golgi  (69  kD)  form  accumulate  in  mutants  which  are 
blocked at these stages of the secretory pathway (Stevens et 
al.,  1982;  Franzusoff and  Schekman,  1989).  Pulse  chase 
studies on whole cell lysates indicated that the transit time 
for CPY processing and transport was similar to wild type 
in myo2-66 mutants (Fig. 4). By 2 min of chase, the ER (pl) 
form of CPY was partially chased into the Golgi (p2) and 
the mature (m) form in  both the mutant and in wild-type 
cells. By 5 min of chase, CPY was completely in its mature 
vacuolar form in both strains. Furthermore, by immunoblot 
analysis, CPY was not inappropriately secreted from myo2- 
66 cells (data not shown). 
Alkaline phosphatase (ALP) is an integral membrane gly- 
coprotein of the  yeast vacuole (Klionsky and Emr,  1989; 
Kaneko et al.,  1987).  ALP is processed from an inactive 
Figure 4. The soluble vacuolar protease carboxypeptidase Y (CPY) 
is processed and transported normally in myo2-66 mutants. Ceils 
(NY 1006, myo2-66, and NY 1033, wt) were shifted to 37°C for 
30 rain, and then were pulse labeled for 2 min with 35S-trans label 
and chased with 10 mM cysteine and methionine for the times indi- 
cated.  At each time point,  ceils were washed into  10 mM NaN3 
and lysed with glass beads. The samples were immunoprecipitated 
with anti-CPY  antibody as described  in Materials  and Methods. 
The final washed,  solubilized precipitates  were loaded onto 8% 
SDS gels and processed  for autoradiography.  The ER precursor 
form of CPY (pl  = 67 kD) is found in both rayo2-66 (A) and wild- 
type (B) samples at the zero time point,  and then it is partially 
chased into the Golgi form (p2 =  69 kD) and mature form (m = 
61 kD) by 2 min in both strains. All of the CPY is in its mature, 
vacuolar form by 5 min in both strains. 
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to the vacuole normally in myo2-66  and wild-type cells. Cells (NY 
1005, myo2-66, and NY 180, wt) were pulse labeled with 35S-trans 
label for 5 min and chased with  10 mM cysteine and methionine 
for 0, 5, and 20 min as described in Fig. 3. The washed, solubilized 
precipitates were loaded onto 10% gels and processed for autoradi- 
ography. Within 5 min of  chase, the precursor form (76 kD) of  ALP 
is converted to the mature 72-kD vacuolar form in both wild-type 
(B) and myo2-66 (A) cells. 
precursor of 76 kD to a mature enzyme of 72 kD upon reach- 
ing  the  vacuole.  Klionsky and  Emr  (1989)  proposed that 
ALP may differ somewhat from CPY in its final targeting to 
the vacuole. To examine this transport pathway, whole cells 
were pulse labeled and immunoprecipitated with anti-ALP 
antibody. In both mutant and wild-type cells, the precursor 
form of ALP was converted to the mature 72-kD enzyme 
within 5 min of chase after a 5-min pulse (Fig. 5). Therefore, 
both a membrane-bound and a soluble vacuolar protein are 
processed and transported efficiently in myo2-66 mutants. 
myo2-66 Cells Are Not Defective in the Transport or 
Internalization of the a-Factor Receptor 
Since we found that neither the secretory pathway nor the 
vacuolar transport pathway are slowed or disrupted in myo2- 
66 cells, we sought to determine if endocytosis or transport 
of a membrane receptor is affected in this mutant. It has re- 
cently been shown that myo2-66 mutants are not defective in 
the uptake of labeled c~ factor (Kubler et al.,  1994), indicat- 
ing that they do not exhibit a defect in receptor-mediated en- 
docytosis. Therefore we examined the transport and consti- 
tutive endocytosis of the a-factor receptor. This receptor is 
normally found on the surface of a  cells where it functions 
to bind the a-factor mating pheromone and induce the mating 
response. The a-factor receptor undergoes internalization af- 
ter a transient association with the cell surface, and is deliv- 
ered to the vacuole via endosome-like structures (Davis et 
al.,  1993).  Once  it  reaches  the  vacuole,  the  receptor  is 
degraded by the PEP4 gene product.  To follow the a-factor 
receptor as it is brought to the cell surface, and then retrieved 
back into the cell, we employed the protocol described by 
Davis  et  al.  (1993).  PEP4  deficient  MY02  and  myo2-66 
strains  were  pulse  labeled  and  chased  as  described  (see 
Materials and Methods) and before spheroplasting, the cells 
were treated with and without protease to degrade any a-fac- 
tor receptor at the  cell  surface.  We  found that  the  trans- 
port of newly synthesized a-factor receptor to the cell surface 
in myo2-66 mutants occurred at rates similar to wild-type 
cells, as a portion of the labeled receptor became accessible 
to exogenous protease within 10 min of chase after a  10-min 
labeling period (Fig. 6). However, from the amount of full- 
length receptor observed at the 10-min chase time (Fig. 6), 
it appears that the amount of receptor that becomes protease 
sensitive in the mutant is somewhat reduced compared to 
wild  type.  Protease  sensitivity  of the  receptor  was  also 
confirmed by the appearance of a  30-kD digestion product 
at the 10-min chase time point (Fig. 6). The a-factor receptor 
became largely inaccessible to protease by 30 min of chase 
in the myo2-66mutant, as indicated by the absence of the 30- 
kD digestion product and the increase in the abundance of 
the full-length protein by 30 min. In contrast, the full-length 
protein was still reduced in abundance at 30 min of chase in 
wild-type cells  and  the  30-kD  proteolytic  fragments per- 
sisted through 90 min of chase.  These results demonstrate 
that a large fraction of a-factor receptor does reach the cell 
surface by 10 min in both the mutant and wild-type strains. 
However, a pool of receptor may either fail to reach the sur- 
face in the myo2-66 cells or it may reach the surface and be- 
come rapidly internalized by  10 min of chase.  A  block in 
receptor export should result in an increased vesicular pool 
of a-factor receptor  in  myo2-66 cells.  However,  no  such 
vesicular pool of a-factor receptor was found in fractionation 
Figure 6.  Surface  accessibility  of the 
a-factor  receptor  in  myo2-66,pep4:: 
URA3 cells.  Mat  ,~,  PEP4 deficient, 
wild-type  (NY 579)  or myo2-66 (NY 
1125) cells were shifted to 30°C for 30 
min, and then pulse labeled for 10 min 
with  35S  in vitro  labeling  mix, chas~l 
with 10 mM cysteine and methionine for 
0,  10, 30, 60, 90, and 150 min, washed 
into  10 mM KF and  NaN3 on ice and 
digested with 1 mg/ml Pronase E for 1 h 
at 37"C before spheroplasting and lysis. 
Both mutant and wild-type strains show 
the receptor protected  from protease at 
zero min, but then at 10 rain of  chase the 
receptor band diminishes,  while  a 30- 
kD  proteolytic  fragment  appears  (ar- 
row), indicating that the receptor has reached the cell surface. The receptor then becomes internalized into a protease-protected compart- 
ment by 30 rain in the mutant  strain as evidenced by the absence of the degradation product,  while in wild-type cells a portion of the 
30-kD fragment persists even at 90 rain of chase. 
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have observed that the a-factor receptor appears to be inter- 
nalized more completely in the myo2-66 mutant (Fig. 6). 
myo2-66 Mutants Accumulate Vesicles Predominantly 
in the Mother Cell upon Short Incubations at 37°C 
Wild-type yeast cells (Fig. 7 a) contain very few secretory 
vesicles within their cytoplasm, as vesicle turnover is rapid. 
Johnston et al. (1991) have shown that in myo2-66 mutants, 
80-100 nm vesicles accumulate throughout the cell after a 
3-h shift to the nonpermissive temperature. To understand 
the origin and destination of these vesicles, we characterized 
the vesicle-accumulation phenotype of myo2-66 cells as a 
function of time and cell polarity through an electron micro- 
scopic study performed on cells synchronized at the small 
budded stage. Mating type "a" cultures were arrested with cz 
factor at the unbudded stage of the cell cycle, and then small 
Figure  7.  Electron  microscopy 
of wild-type or sect-4  ceils 
shifted to 37°C  for I0 min. 
Cells  were prepared for  TEM 
as  described in Materials and 
Methods. a is  a  representative 
wild-type  cell  0NY 13) which 
does  not  accumulate secretory 
vesicles, and  b  is a typical 
see6-4  (NY  17) cell  showing 
vesicle accumulation  mainly 
in the bud. Bar, 1 #rn. 
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temperature. Cells were then shifted to 37°C for 0, 10, or 20 
min,  and  subsequently fixed and  sectioned for TEM  (see 
Materials and Methods). 
In two post-Golgi sec mutants, secl-I and sec6-4, upon a 
short incubation at the nonpermissive temperature,  secre- 
tory vesicles accumulated within the bud of the cell (Fig. 7 
b). These cells showed a quantitative increase in both vesicle 
number and vesicle density in the bud up until  15 min at 
37°C (Fig.  10 A). After this time point, the vesicle density 
in the mother cell (mainly the neck region) began to increase 
as the bud was saturated (Fig. 10 B). This reflects the inabil- 
ity of these vesicles to fuse with the plasma membrane of  the 
bud. In contrast, myo2-66 cells shifted to 37°C for 10 rain 
accumulated vesicles almost exclusively in the mother cell 
(Fig. 8 b). Even at the permissive temperature (0 min) myo2- 
66  cells  showed  some  vesicle  accumulation  within  the 
cytoplasm of  the mother cell and few vesicles in the bud (Fig. 
8 a). After 20 rain (Fig. 8 c) at the restrictive temperature, 
myo2-66 mutant cells continued to show increased vesicle 
accumulation predominantly in the mother cell while few 
vesicles were found in the bud.  Quantitation of vesicle ac- 
cumulation in myo2-66 cells confirmed that the number and 
density of vesicles in the mother cell increased linearly with 
time (Fig. 10 B), while staying constant, and low in number, 
in the bud (Fig. 10 A). This phenotype of myo2-66 cells indi- 
cates a defect in the transport and/or fusion of vesicles with 
their correct target membrane and may reflect a  block in 
vesicle transport into the bud. 
EM of  Double Mutants 
Phenotypic analysis of  double mutants can establish epistatic 
relationships (Huffaker et al.,  1988; Kaiser and Schekman, 
1990; Novick et al.,  1981).  We first sought to identify the 
relationship of MY02 function with respect to the function 
of three different classes of SEC genes: those involved in ER 
to Golgi, intra-Golgi, or post-Golgi transport. Since the EM 
phenotype of the various sec mutants is deafly distinct from 
the myo2-66 phenotype, we were able to establish the rela- 
tionships between several of these gene functions by per- 
forming EM analysis on various double mutants. 
If MY02 functions in a SEC-dependent pathway,  a double 
mutant  should  exhibit  a  phenotype  reflecting the  earlier 
block. A myo2-66, sect-4 double mutant was initially exam- 
ined.  sec6-4 mutants  accumulated  post-Golgi  secretory 
vesicles in the bud when shifted to the restrictive tempera- 
ture (Fig. 7 b). In contrast, the myo2-66, sec6-4 double mu- 
tant accumulated vesicles in the mother cell (Fig.  9 a), as 
did the myo2-66 single mutant (Fig. 9 b). The quantitation 
of vesicle density in the mother and bud of the myo2-66, 
sec6-4 mutant was similar to the myo2-66 single mutant in 
that vesicle accumulation in the mother cell increased with 
time but remained constant in the bud (Fig. 10, A and B and 
Table 11I). Thus,  by this  criteria alone, MY02  appears  to 
function before SEC6. However, unlike the myo2-66 mutant, 
the myo2-66, sec6-4 double mutant displays the same tight 
block in invertase secretion as the sec6-4 mutant alone (data 
not shown). Thus myo2-66does not bypass a SEC6-requiring 
step in the secretory  pathway. Taken together, the EM pheno- 
type combined with the assay for internal invertase in the 
double mutant shows that this double mutant exhibits some 
phenotypic characteristics of each single mutant. 
Figure 8. Tune course of rayo2-66 cells shifted to 370C for short 
periods. Cells (NY 829) were synchronized with c~ factor, released 
from G1 arrest, and allowed to form small buds at 25°C, and then 
incubated at 37°C for the following times (a) 0 rain, (b) 10 rain, 
and (c) 20 min.  At the various time points, cells were fixed for 
TEM. Vesicle accumulation occurs predominantly in the mother 
cell with time, while few vesicles appear in the bud. Bar, 1/zm. 
To define the myo2-66 block with respect to other land- 
marks on the secretory pathway,  double mutants in which 
myo2-66  was combined with ER to Golgi blocked sec alleles 
were examined. SEC13 facilitates ER to Golgi transport by 
catalyzing the budding  of carrier vesicles (Salama et al., 
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branes at the restrictive temperature.  Double mutant, secl3-1, 
myo2-66,  cells  displayed  the  same  morphological pheno- 
type as the secl3-1 single mutant (Fig.  9 b).  SEC18 is also 
required for transport between the ER and Golgi complex, 
catalyzing the fusion of carrier vesicles (Rexach and Schek- 
man,  1991; Graham  and  Emr,  1991). A  secl8-1  mutant 
builds  up ER membranes and  small  (50  nm)  ER-derived 
transport vesicles at the restrictive temperature (Novick et 
al., 1981). Double mutant, myo2-66, sec18-1, cells also accu- 
mulated ER membranes and some small vesicles at the non- 
permissive temperature (Fig.  9 d).  Thus,  Secl3 and Secl8 
Figure 9. Electron microscopy of double mutants between myo2-66 and representative sec mutants after 10 rain at 37°C. Double mutants 
were constructed and prepared for TEM as described in Materials and Methods. (a) myo2-66,sec6-4 (NY 895) accumulates vesicles pre- 
dominantly in the mother cell, as seen in the myo2-66  single mutant. (b) myo2-66,sed3-1  (NY 922) accumulates only ER membrane as 
observed in the secl3-1 single mutant. (c) myo2-66,sec7-1 (NY 919) accumulates Golgi membranes as does the sec7-1 single mutant. (d) 
myo2-66,sed8-1  (NY 896) accumulates both ER-derived vesicles and ER membrane as does the sec18-1 single mutant. Bar, 1 tzm. 
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Figure I0. Quamitation of vesicle accumulation in the bud (.4) and 
mother cell (B) of sec6-4, secl-1, myo2-66, and {myo2-66,sec6-4} 
ceils. Vesicle density was determined as described in Materials and 
Methods. In secl-I (open square) and sec6-4 (filled square) cells, 
vesicles accumulate in the bud linearly with time, whereas in myo2- 
66 mutants  (open circle), vesicle accumulation  occurs  preferen- 
tially in the mother cell with time, and the vesicle number and den- 
sity in the bud remains low. The myo2-66,sec6-4 double mutant 
(filled circle) exhibits the same vesicle density profile as the myo2- 
66 single mutant. 
must be active in order to generate the  vesicles found in 
myo2-66 cells. 
Next,  a  secT-l, myo2-66  double  mutant  was  examined. 
SEC7 is involved in intra-Golgi transport and possibly ER- 
Golgi  transport  (Franzusoff and  Schekman,  1989;  Fran- 
zusoffet al., 1991). At the nonpermissive temperature secT-1 
mutant cells accumulate Golgi membranes which  are not 
readily observed in wild-type yeast cells by usual  fixation 
methods,  sec7-1, myo2-66  double  mutant  cells  shifted  to 
37°C  also exhibited the characteristic  Golgi stacks of the 
secT-1 mutant  (Fig.  9  c).  Therefore,  myo2-66  appears  to 
block after secT-l, and  Sec7  function  is  required  to  form 
myo2-66 vesicles. 
Finally, to determine whether the vesicles in the myo2-66 
mutant  could  be derived  from an  endocytic  or  recycling 
pathway,  we constructed  double mutants of myo2-66  with 
representatives from two stages of the endocytic pathway. 
Table 111. * Vesicle Accumulation  in myo2-66 and sec6-4 
Mutants at 37°C 
Average num- 
Time  Density  bet of vesicles 
at 
Strain  37"C  Bud  Mother  Bud  Mother 
min  (vesicles/gra 2) 
secl-1  0  6.6  +  5.0  0.5  +  0.2  12.2  5.6 
10  17.2  -/- 5.5  1.0  +  0.3  46.0  12.9 
20  27.2 +  8.0  2.7  5= 0.9  46.0  40.7 
sec6-4  0  18.6 5= 8.9  1.0 +  0.4  21.1  10.4 
5  27.2 5:8.6  1.7 +  1.0  48.1  20.6 
10  33.4 5=  10.4  2.5  5=  1.1  59.3  32.3 
15  37.8 5= 9.8  5.2  5=  1.4  59.0  60.1 
myo2-66  0  7.5  +  2.2  5.0 5= 2.1  17.0  67.0 
10  6.9  5= 2.3  7.3  5=  1.9  16.0  104 
20  7.5  5= 2.3  9.5  5= 2.2  16.0  137 
myo2,sec6  0  3.2  5= 2.4  3.1  +  2.7  9.0  47.0 
10  3.3  + 2.3  5.5  + 2.2  8.3  80.0 
20  3.5  +  2.3  7.9  +  2.7  9.8  114 
* The density and number of vesicles located in both the bud and mother cell 
of secl-1, sec6-4, myo2-66, and {myo2-66,sec6-4}  cells after brief incubations 
at 37°C.  Vesicle density was determined by dividing the number of vesicles 
within a particular region of  the cell (bud or mother) by the corresponding area. 
Each value is the average of measurements made on 25-30 individual cells from 
1-3  independent experiments  + SD. 
REN1 functions in a  late stage of endocytosis, possibly in 
transport from the endosome to the vacuole (Davis et al., 
1993). myo2-66/renlA double mutants still accumulate vesi- 
cles at the restrictive temperature (data not shown). Since the 
renA  cells  alone  do  not  accumulate  any  organelles  (not 
shown), the vesicles in myo2-66 cells are not derived from 
an endosome-to-vacuole pathway. END4 encodes a protein 
which  functions  in the  internalization  step of endocytosis 
(Raths et al., 1993). We reasoned that if Myo2 acts in trans- 
porting endocytic or recycling vesicles, blocking internaliza- 
tion  should  prevent the  accumulation  of such  vesicles.  A 
myo2-66/end4A double mutant was constructed and shifted 
to 37°C for 2 h,  along with the respective single mutants. 
Fig.  11  shows that like the myo2-66 single mutant (B), the 
myo2-66/end4A  double mutant (C) still accumulates vesi- 
cles within its cytoplasm. It should be noted that the numbers 
of vesicles in the single and double mutants are variable, pos- 
sibly due to the heterogenous cell populations.  It is clear, 
however, that preventing the internalization step of endocyto- 
sis does not block vesicle formation in myo2-66 mutants. 
Taken together, our EM studies indicate that Myo2 func- 
tions in a pest-Golgi, SEC-dependent transport pathway with 
a terminal phenotype before sec6-4, but after that ofsecl3-1, 
sec18-1, and secT-1. We have also ruled out the possiblity that 
the vesicles in the myo2-66mutant could be derived from an 
endocytic pathway, since blocking endocytosis does not pre- 
vent vesicle accumulation in these cells. From the EM data 
alone, the vesicles in the myo2-66mutants  appear to be inter- 
mediates of the post-Golgi secretory pathway. Several models 
are considered below to account for the various lines of evi- 
dence concerning the cellular function of the Myo2 protein. 
Discussion 
We have presented further characterization of the myo2-66 
mutant, and investigated the possible role of Myo2 in various 
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after 2 h at 37"C. Double mutants of myo2-66 and end4::LEU2 
were constructed and confirmed by complementation. Single or 
double mutant cells were shifted to 37"C for 2 h, and then fixed 
and processed for TEM. (A) end4A cells (NY 1180) alone do not 
accumulate any organdies within their cytoplasm.  (B) rayo2-66 
cells (NY  1005) accumulate many vesicles (arrow) within their 
cytoplasm. (C) myo2-66,end4::LEU2 double mutants (NY 1235) 
also accumulate vesicles (arrows) within their cytoplasm, The de- 
gree of  vesicle accumulation among B and C is somewhat variable, 
perhaps due to the asynchronous cell populations. Bar, 1 ~m. 
vesicular transport pathways.  First, we examined the genetic 
interactions of this mutation with known sec mutations, and 
found that myo2-66 displays synthetic lethality with a subset 
of post-Golgi blocked sec mutations, but not with any muta- 
tions which act earlier in the secretory pathway. These inter- 
actions suggest that Myo2 functions on a pathway that also 
requires the late-acting SEC gene products. We can therefore 
speculate that Myo2 facilitates a transport pathway that in- 
volves fusion of vesicles with the plasma membrane, and not 
in transport from the ER to the Golgi complex.  Liu and 
Bretscher (1992) have reported that myo2-66 is synthetically 
lethal with a disruption of  the yeast tropomyosin gene, TPM/, 
and since the mutant phenotype of TPM/disrupted cells is 
very similar to myo2-66 mutants (Liu and Bretscher, 1992), 
the two genes may be involved in concerted functions. 
The myo2-66 mutant was previously shown to accumulate 
vesicles within its cytoplasm upon a 3-h shift to the restric- 
tive temperature. We have observed that upon short shifts to 
37°C, vesicles accumulate predominantly in the mother cell, 
and not in the bud of myo2-66 ceils. This is in contrast to 
the pattern we observed in late-acting sec mutants, such as 
sec6-4 and secl-1, in which vesicles are found predominantly 
in the bud after brief incubations at the restrictive tempera- 
ture. In the case of sec6-4 and secl-1, post-Golgi secretory 
vesicles reach the bud, but are unable to fuse with its plasma 
membrane.  In  the  myo2-66  mutant,  however, vesicle ac- 
cumulation  in  the mother cell may  reflect a  targeting  or 
delivery defect, and this is consistent with a model in which 
Myo2 acts as a motor to move vesicles from the mother cell 
into the bud. Alternatively, it may reflect a defect in segregat- 
ing components of the secretory apparatus, such as the Golgi 
complex, into the bud. Analogous phenotypes have been ob- 
served in dilute mice and unc-104 mutants of C. elegans. In 
the case of  dilute, loss of  function of  this class V myosin leads 
to a defect in the transport of pigment granules in melano- 
cytes (Mercer et al., 1991). In the case ofunc-104, the defect 
in this kinesin-related gene product causes the accumulation 
of synaptic vesicles specifically in the neuronal cell bodies 
due to a  failure in anterograde axonal transport (Hall and 
Hedgecock,  1991). 
Even though myo2-66 cells rapidly accumulate vesicles, 
previous studies demonstrated that bulk secretion still con- 
tinues  in these  cells,  although perhaps  in  a  nonpolarized 
fashion. The appearance of vesicles without a concomitant 
block in protein export led to the proposal that secretion con- 
tinues because secretory vesicles make their way to the cell 
surface more slowly in the myo2-66 mutant (Johnston et al., 
1991).  This hypothesis would predict a  kinetic lag  in the 
transport of secretory proteins.  We have shown,  however, 
that there is no detectable lag in the transport of a number 
of secreted, cell surface or vacuolar proteins in myo2-66 
cells.  It is  possible that  secretory proteins accumulate  in 
myo2-66 vesicles, but get degraded. However, in our pulse- 
chase experiments, we have not observed any degradation 
products or internal intermediates. It should be noted that af- 
ter a shift to 370C, wild-type ceils mislocalize actin (by im- 
munofluorescence) for up to 60 min. It is possible that Myo2 
might normally act to speed vesicular transport, but the loss 
of actin polarity resulting from the temperature shift masks 
this effect. However, a temperature shift does not, by itself, 
slow secretion or result in the accumulation of vesicles. The 
efficient vesicular transport seen in wild-type cells after a 
temperature shift presumably reflects the presence of resid- 
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cence, since temperature sensitive actin mutants do exhibit 
a partial block in secretion as well as vesicle accumulation. 
The absence of a secretory block in myo2-66 cells might 
indicate that vesicles can use an alternate cytoskeletal track 
and motor to move into the bud. This is an appealing pro- 
posal since a kinesin-like suppressor of myo2-66 has been 
identified (Lillie and  Brown,  1992).  In  squid  axoplasm, 
crosstalk between microtubule-based and actin-based trans- 
port mechanisms has been observed; vesicles were found to 
switch from moving along microtubules to actin filaments se- 
quentially  (Kuznetsov et  al.,  1992).  In  addition,  Golgi- 
derived vesicles in the brush border possess both dynein and 
myosin-I, suggesting that a vesicle can use more than one 
cytoskeletal track (Fath et al.,  1994).  However,  we found 
that disrupting microtubules with nocodazole in myo2-66 
cells does not lead to a tighter block in invertase or glycopro- 
tein secretion. This suggests that Myo2 does not operate in 
parallel with a microtubule-based transport system. 
One could postulate that the myo2-66 vesicles contain a 
specific subset of secretory proteins that are as yet uniden- 
tiffed, and in a recent review, Bretscher et al. put forth a simi- 
lar proposal to resolve the surprising observation of vesicle 
accumulation without concomitant secretory defects in both 
myo2-66and tpml mutants (Bretscher et al., 1994). It is pos- 
sible that Myo2 and Tpml both function on a pathway that 
requires the late SEC gene products, but which facilitates the 
transport of a specific class of proteins. Since myo2-66 was 
originally identified as a cell cycle mutant, cdc66-1 (John- 
ston, 1991), it may be that the vesicles which accumulate in 
this mutant contain cargo needed for a particular stage of the 
cell cycle. The cargo of the myo2-66 vesicles could be com- 
ponents necessary for cell wall assembly, such as chitin syn- 
thetases, chitinase, or endoglucanases. Alternatively, they 
could ferry proteins needed for mating (e.g., Fusl). Once a 
marker for purifying these vesicles is found, analysis of the 
composition and cargo of the vesicles should be enlighten- 
ing. Recently, two classes of post-Golgi secretory vesicles 
have been identified in a late-acting sec mutant (Harsay, E., 
and A. Bretscher.  1994. Mol. BioL Cell. 5:443a). If Myo2 
were required for transport of only one set of vesicles, then 
the other set should still accumulate in the bud of the myo2- 
66, sec6-4 double mutant. However, our EM analysis of the 
double mutant indicates that there is no large class of vesicles 
transported to the bud in a Myo2 independent fashion. Per- 
haps the invertase-containing vesicles represent only a mi- 
nor pool of the total post-Golgi vesicles. Another possible 
model is that Myo2 is required to move both types of vesicles 
into the bud.  The subset of vesicles which accumulate in 
myo2-66 cells must be targeted to the bud in order to fuse, 
while the invertase-containing vesicles can fuse equally well 
with the plasma membrane of the mother cell. This model 
is consistent with the very large mother cells seen in myo2-66 
cultures. 
The Myo2 protein is found predominantly at the tip of the 
bud in wild-type yeast (Lillie and Brown,  1994) and along 
with calmodulin and actin, it changes its distribution through- 
out the cell cycle to regions of active growth (Brockerhoff et 
al., 1994).  This localization may reflect the destination of a 
Myo2-dependent transport pathway involved in establishing 
and maintaining polarized growth. However,  we must also 
consider other, less direct, roles for Myo2 in vesicular trans- 
port. An alternate function of  Myo2 may be to organize polar- 
ized growth at the cell surface by recruiting components re- 
quired for bud assembly and growth. Myo2 may facilitate the 
polarized distribution of these bud site proteins by organiz- 
ing the actin cytoskeleton. Finally, Myo2 may also act to 
support the dynamic changes of the actin-plasma membrane 
interface in facilitating cell wall growth (see Mulholland et 
al., 1994). To sort out these possible avenues of Myo2 func- 
tion, it will be important to determine if Myo2 functions on 
the surface of the vesicles and/or at the plasma membrane. 
We would like to thank Dr. G. Johnston for the myo2-66 strain. We would 
also like to thank the following for their generous gifts of antibodies: Drs. 
N. Davis and G. Sprague (anti a-factor receptor), Dr. T. Stevens (alkaline 
phosphatase), Dr.  S.  Ferro-Novick  (invertase and c~ factor),  and Dr.  P. 
Brennwald (carboxypeptidase Y). We are grateful to Dr. N. Davis and Dr. 
S. Brown for sharing results before publication. We would like to thank Drs. 
R. Cheney, R. Collins, and M. Mooseker for their critical reading of the 
manuscript, H. Tan for his assistance in photography, and L. Vanacore for 
her assistance in thin section electron microscopy. 
This work was supported by grants to P. Novick from the National Insti- 
tutes of Health (GM35370) and the Donaghue Foundation. B. Govindan and 
R. Bowser were supported by predoctoral training grants. 
Received for publication 10 October 1994 and in revised form 20 December 
1994. 
References 
Adams, A. E. M., and J. R. Pringle.  1984. Relationship of actin and tubulin 
distribution to bud growth in wild-type and morphogenetic-mutant Sac- 
charomyces cerevisiae. J.  Cell Biol. 98:934-945. 
Amatruda, J. F., J. F. Cannon, K. Tatchell, C. Hug, andJ. A. Cooper. 1990. 
Disruption of the actin cytoskeleton in yeast capping protein mutants, Nature 
(Lond.).  344:352-354. 
Bretscher, A., B. Drees, E. Harsay, D. Schott, and T. Wang. 1994. What are 
the basic functions  of microfilaments?  Insights  from studies in budding yeast. 
J.  Cell BioL 126:821-825. 
Brockerhoff,  S. E., R. C. Stevens, and T. N. Davis. 1994. The unconventional 
myosin, Myo2p,  is a  caimodulin target at  sites of cell  growth in Sac- 
charomyces cerevisiae. J.  Cell Biol. 124:315-323. 
Brown, S. S. 1993. Phenotypes of cytoskeletal  mutants. Curr. Opin. Cell Biol. 
5:129-134. 
Carlson, M., and D. Botstein.  1982. Two differentially  regulated mRNAs with 
different 5' ends encode secreted and intracellular forms of yeast invertase. 
Cell. 28:145-154. 
Cheney, R. E., and M. S.  Mooseker.  1992.  Unconventional myosins, Curr. 
Opin.  Cell Biol. 4:27-35. 
Cheney, R. E., M. K. O'Shea, J. E. Heuser, M. V. Coelho, J. S. Wolenski, 
E. M. Espreafico,  P. Forscher, R. E. Larson, and M. S. Mooseker.  1993. 
Brain myosin-V is a two-headed unconventional myosin with motor activity. 
J.  Cell Biol. 75:13-23. 
Davis, N. G., J. L. Horecka, and G. F. Sprague.  1993.  Cis- and trans-acting 
functions required for endocytosis of the yeast pheromone receptors. J. Cell 
Biol.  122:53-65. 
Esmon, B., P. Novick, and R. Schekman. 1981. Compartmentalized assembly 
of oligosaccharides on exported glycoproteins in yeast. Cell. 25:451-460. 
Espindola, F. S., E. M. Espreafico, M. V. Coelho, A. R. Martins, F. R. C. 
Costa, M. S. Mooseker, and R. E. Larson. 1992. Biochemical and immuno- 
logical characterization of plgO-calmodulin complex from vertebrate brain: 
a novel calmodulin-binding myosin. J.  Cell Biol. 118:359-368. 
Espreafico, E. M., R. E. Cheney, M. Matteoli, A. A. C. Nascimento, P. V. 
De Camilli, R. E. Larson, and M. S. Mooseker.  1992.  Primary structure 
and cellular localization  of chicken brain myosin-V (pig0), an unconven- 
tional myosin with calmodulin light chains. J.  Cell Biol. 119:1541-1557. 
Fath, K. R., G. M. Trimbur, and D. R. Burgess. 1994. Molecular motors are 
differentially distributed on Golgi membranes  from polarized epithelial cells. 
J.  Cell Biol. 126:661-675. 
Franzusoff, A., and R. Schekman. 1989. Functional compartments of the yeast 
Golgi apparatus are defined by the sec7 mutation. EMBO (Eur. Mol. Biol. 
Organ.) J.  8:2695-2702. 
Franzusoff, A., K. Redding, J. Crosby, R. S. Fuller, and R. Schekman. 1991. 
Localization  of components involved in protein transport and processing 
through the Golgi apparatus. J.  Cell Biol. 112:27-37. 
Graham, T. R., and S. D. Emr.  1991. Compartmental organization of Golgi- 
specific protein modification  and vacuolar protein sorting events defined in 
a yeast secl8 (NSF)  mutant. J.  Cell Biol. 114:207-218. 
Haarer, B. K., S. H. LiUie, and S. S. Brown.  1994.  Identification  of MY04, 
a second class V myosin gene in yeast. J.  Cell Sci. 107:1055-1064. 
Hall, D. H., and E. M. Hedgecock. 1991. Kinesin-related gene unc-104 is re- 
Govindan et al.  The Role of Myo2 in  Vesicular Transport  1067 quired for axonal transport of synaptic vesicles in C,  elegans.  Cell.  65: 
837-847. 
Holtzman, D. A., S. Yang, and D. G. Drnbin. 1993. Synthetic-lethai  interac- 
tions identify two novel genes, SIAl  and  SIA2,  that control membrane 
cytoskeleton assembly in  Saccharomyces  cerevisiae.  J.  Cell  Biol.  122: 
635-644. 
Huffaker, T.  C., J.  H.  Thomas, and D.  Botstein.  1988.  Diverse effects  of 
B-tuhnlin mutations on microtubule formation and function. J.  Cell Biol. 
106:1997-2010. 
Ito, H., Y. Fukuda, K. Murata, and A. Kimura. 1983. Transformation of intact 
yeast cells with alkali  cations. J. Bacteriol.  153:163-168. 
Johnston, G. C., J. A. Prendergast, and R. A. Singer. 1991.  The Saccharo- 
myces cerevisiae MY02 gene encodes an essential myosin for vectorial trans- 
port of vesicles. J.  Cell Biol.  113:539-551. 
Julius, D., R. Schekman, and J. Thorner. 1984a. Glycosylation and processing 
of prepro-cx-factor through the yeast secretory pathway. Cell.  36:309-318. 
Julius, D., A. Brake, L. Blair, R. Kunisawa, and J. Thorner. 1984b. Isolation 
of the putative structural gene for the lysine-arginine-cleaving  endopeptidese 
required for processing of yeast prepro-c~-factor.  Cell.  37:1075-1089. 
Kaiser, C. A., and R. Schekman. 1990. Distinct sets of SEC genes govern trans- 
port vesicle formation and fusion early in the secretory pathway.  Cell. 
61:723-733. 
Kaneko, Y., N. Hayashi, A. Toh-e, L Banno, and Y. Oshima. 1987. Structural 
characteristics of the PH08 gene encoding repressible alkaline phosphatase 
in S.  cerevisiae.  Gene (Amst.).  58:137-148. 
Kilmartin, J.  V., and A. E. M.  Adams. 1984.  Structural rearrangements of 
tuhnlin and actin during the cell cycle of the yeast Saccharomyces.  J.  Cell 
Biol.  98:922-933. 
Klionsky, D. J., and S. D. Emr. 1989. Membrane protein sorting: biosynthesis, 
transport and processing of yeast vacuolar alkaline  phosphatase. EMBO 
(Fur. Mol.  Biol.  Organ.)J.  8:2241-2250. 
Kubler, E., and H. Riezman. 1993. Actin and fimbrin are required for the inter- 
nalization  step of endocytosis in yeast. EMBO (Fur. Mol.  Biol.  Organ.) J. 
12:2855-2862. 
Kubler, E.,  F.  Schimmoller, and H.  Riezman.  1994.  Calcium-independent 
calmodulin requirement for endocytosis in yeast. EMBO (Eur. Mol.  Biol. 
Organ.) J.  13:5539-5546. 
Kuznetsov, S. A., G. M. Langford, and D. M. Weiss. 1992. Actin-dependent 
organelle movement in squid axoplasm. Nature (Lond.).  356:722-725. 
Lillie, S. H., and S. S. Brown.  1992.  Suppression of a myosin defect by a 
kinesin-related gene. Nature (Lond.).  356:358-361. 
LiUie, S. H., and S. S. Brown. 1994. Immunofiuorescence  localization  of the 
unconventional myosin, Myo2p, and the putative kinesin-related protein, 
Smylp, to regions of growth in Saccharomyces  cerevisiae.  J.  Cell Biol. 
125:825-842. 
Liu, H., and A. Bretscher.  1992.  Characterization of TPM1 disrupted yeast 
cells indicates an involvement  of  tropomyosin in directed vesicular transport. 
J.  Cell Biol.  118:285-299. 
Madden, K., C. Costigan, and M. Snyder. 1992. Cell polarity and morphogene- 
sis in Saccharomyces cerevisiae.  Trends  Cell Biol.  2:22-29. 
Mercer, J. A., P. K. Seperack,  M. C. Strobel, N. G. Copeland, and N. A. 
Jenkins. 1991.  Novel myosin heavy chain encoded by Murine dilute  coat 
color locus. Nature (Lond.).  349:709-712. 
Mulholland, J., D. Preuss, A. Moon, A. Wong, D. Drubin, and D. Botstein. 
1994. Ultrastructure of the yeast actin cytoskeleton and its association with 
the plasma membrane. J.  Cell Biol.  125:381-391. 
Novick, P., and R. Schekman. 1983.  Export of major cell surface proteins is 
blocked in yeast secretory mutants. J.  Cell Biol.  96:541-547. 
Novick,  P.,  and  D.  Botstein.  1985.  Phenotypic analysis of temperature- 
sensitive yeast actin mutants. Cell. 40:405-416. 
Novick, P., C. Field, and R. Schekman. 1980. Identification of 23 complemen- 
ration  groups required for post-translational events in the yeast secretory 
pathway. Cell.  21:205-215. 
Novick, P., S. Ferro, and R. Schekraan.  1981.  Order of events in the yeast 
secretory pathway. Cell.  25:461-469. 
Preuss, D., J. Mulhnliand, A. Franzusoff, N. Segev, and D. Botstein. 1992. 
Characterization of the Saccharomyces Goigi complex through the cell cycle 
by immunoelectron microscopy. Mol.  Biol.  Cell.  3:789-803. 
Raths, S., J. Rohrer, F. Crausaz, and H. Riezman. 1993. end3 and end4: two 
mutants defective in receptor-mediated and fluid-phase endocytosis in Sac- 
charomyces cerevisiae.  J.  Cell Biol.  120:55-65. 
Raymond, C. K., I. Howald-Stevenson, C. A. Vater, and T. H. Stevens. 1992. 
Morphological classification  of the yeast vacuolar protein sorting mutants: 
evidence for a prevacuolar compartment in class E vps mutants. Mol.  Biol. 
Cell.  3:1389-1402. 
Rexach, M. F., and R. Scheknmn. 1991. Distinct biochemical requirements for 
the budding, targeting and fusion of ER-derived transport vesicles. J.  Cell 
Biol.  114:219-229, 
Saiama, N. R., T. Yeung, and R.W. Schekman. 1993. The Secl3p complex 
and reconstitution of vesicle budding from the ER with purified cytosolic 
proteins. EMBO (Eur. biol,  Biol.  Organ.) J.  12:4073--4082. 
Salminen, A., and P. J. Novick. 1987. A ras-like protein is required for a post- 
Golgi event in yeast secretion. Cell. 49:527-538. 
Sherman, F., G. Fink, and C. Lawrence. 1974.  Methods in Yeast Genetics. 
Cold Spring Harbor Laboratory, Cold Spring Harbor, New York. 
Stevens, T., B. Esmon, and R. Schekman. 1982. Early stages in the yeast secre- 
tory pathway are required for transport of  carboxypaptidase Y to the vacuole. 
Cell.  30:439-448. 
Titus, M. A. 1993. From fat yeast and nervous mice to brain myosin-V. Cell. 
75:9-11. 
Vide, T. A., G. Huyer, and S. D. Emr. 1993. Yeast vacuolar proenzymes are 
sorted in the late  Golgi  complex and transported to  the vacuole via a 
prevacuolar endosome-like compartment. J.  Cell Biol.  121:1245-1256. 
Waiworth, N., and P. Novick. 1987. Purification  and characterization of consti- 
tutive secretory vesicles from yeast. J.  Cell Biol.  105:163-174. 
Watts, F. Z., G. Shiels, and E. Orr.  1987. The yeast MYOI gene encoding a 
myosin-like protein required for cell division. EMBO (Fur. Mol.  Biol.  Or- 
gan.) J.  6:3499-3505. 
Welch, M.  D., D. A. Holtzman, and D. G.  Drubin.  1994.  The yeast actin 
cytoskeleton. Curr.  Opin.  Cell Biol.  6:110-119. 
Wilcox,  C.,  and  R.  S.  Fuller.  1991.  Posttranslational  processing of the 
prohormone-cleaving  Kex2 protease in the Saccharomyces cerevisiae secre- 
tory pathway. J.  Cell Biol.  115:297-307. 
The Journal of Cell Biology, Volume 128,  1995  1068 